Hjem › Myelofibrose
Myelofibrose kliniske forsøg rekrutterer i USA
56 studier for Myelofibrose rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Houston, TX19 studier
- New York City, NY18 studier
- Boston, MA12 studier
- Durham, NC12 studier
- Columbus, OH11 studier
- Seattle, WA11 studier
- Salt Lake City, UT10 studier
- Miami, FL10 studier
- Nashville, TN9 studier
- Atlanta, GA9 studier
- Tampa, FL9 studier
- Cleveland, OH9 studier
- Baldwin Park, CA9 studier
- St. Louis, MO8 studier
- Ann Arbor, MI8 studier
- Chicago, IL7 studier
- Baltimore, MD7 studier
- Birmingham, AL7 studier
- Mountain View, CA7 studier
- Los Angeles, CA6 studier
- Philadelphia, PA6 studier
- Winston-Salem, NC6 studier
- Irvine, CA5 studier
- Kansas City, MO5 studier
- Portland, OR5 studier
- Dallas, TX5 studier
- Cincinnati, OH5 studier
- Milwaukee, WI4 studier
- New Haven, CT4 studier
- Charlotte, NC4 studier
- Denver, CO4 studier
- Minneapolis, MN4 studier
- Edison, NJ4 studier
- Washington, DC4 studier
- Jacksonville, FL4 studier
- The Bronx, NY3 studier
- Sacramento, CA3 studier
- Coral Springs, FL3 studier
- Orange, CA3 studier
- Charleston, SC3 studier
Efter delstat
- Alabama7 studier
- Arizona7 studier
- Californien21 studier
- Colorado6 studier
- Connecticut5 studier
- Florida14 studier
- Georgia9 studier
- Illinois7 studier
- Kansas6 studier
- Maryland9 studier
- Massachusetts13 studier
- Michigan10 studier
- Minnesota7 studier
- Missouri8 studier
- New Jersey6 studier
- New York21 studier
- North Carolina17 studier
- Ohio17 studier
- Oregon6 studier
- Pennsylvania8 studier
- South Carolina4 studier
- Tennessee9 studier
- Texas20 studier
- Utah10 studier
- Virginia5 studier
- Washington11 studier
- Wisconsin5 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04176198A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07357727A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07469891Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07521046A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07623161A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06661915Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RekruttererTidlig fase 1
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06398457Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT05320198Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT04282187A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT06343805High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 16. sep. 2026 · NCT06345495Pacritinib Effectiveness in Real-world Settings
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07774455A Telehealth Advance Care Planning Intervention
Rekrutterer
Alder 60 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT05875805Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 19. aug. 2026 · NCT07228624TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
RekruttererFase 1
Alder 18 til 80 · Alle køn · Opdateret 17. aug. 2026 · NCT07302776A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT07008118Quantitative MRI for Myelofibrosis
RekruttererObservationsstudie
Alder 18 til 99 · Alle køn · Opdateret 31. jul. 2026 · NCT01973881A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. jul. 2026 · NCT06773195A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 75 · Alle køn · Opdateret 28. jul. 2026 · NCT07020533Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. jul. 2026 · NCT07441694A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 20. jul. 2026 · NCT07250646Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 20. jul. 2026 · NCT04370301Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 15. jul. 2026 · NCT07128381Allo HSCT Using RIC and PTCy for Hematological Diseases
RekruttererFase 2
Op til 75 år · Alle køn · Opdateret 6. jul. 2026 · NCT05805605Registry of Older Patients With Cancer
RekruttererObservationsstudie
Alder 65 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT01137825Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.